YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Pharma's Overachievers and Slackers in 2013


January 2, 2014 | Pharma reporter Matthew Herper offers letter grades to the 16 largest drug companies for their 2013 performance. Highlights include the ethical reforms at GlaxoSmithKline, rapid industry-wide progress in treating hepatitis C, and immunotherapy for cancer at Herper's 2013 favorite, Bristol-Myers Squibb. Forbes
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.